Pricing Cancer Drugs: When Does Pricing Become Profiteering?
Senior associate editor of the AMA Journal of Ethics.
Hannah L
HL
Kushnick
D000970:Antineoplastic Agents / Q000191:economics*; D016527:Drug Costs / Q000639:trends*; D016568:Drugs, Generic / Q000191:economics*; D006801:Humans; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000191:economics*; D010330:Patents as Topic
D000970:Antineoplastic Agents; D016568:Drugs, Generic